Background The antiviral efficacy of remdesivir against SARS-CoV-2 is still controversial.
We aimed to evaluate the clinical efficacy of remdesivir plus standard of care compared with …

Importance Evidence supporting the choice of intravenous colloid vs crystalloid solutions for
management of hypovolemic shock remains unclear. Objective To test whether use of …

Background : Vasopressor agents could have certain specific effects in patients with
cardiogenic shock (CS) after myocardial infarction, which may influence outcome. Although …

The characterization of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viral
kinetics in hospitalized patients and its association with mortality is unknown. We analyzed …

Vasoplegia is a ubiquitous phenomenon in all advanced shock states, including septic,
cardiogenic, hemorrhagic, and anaphylactic shock. Its pathophysiology is complex, involving …

Lactic acidosis is a very common biological issue for shock patients. Experimental data clearly
demonstrate that metabolic acidosis, including lactic acidosis, participates in the reduction …

Background Patients with sepsis-induced cardiomyopathy with cardiogenic shock have a
high mortality. This study assessed venoarterial extracorporeal membrane oxygenation (VA-…

Aims The role of extracorporeal membrane oxygenation (ECMO) remains ill defined in
pulmonary embolism (PE). We investigated outcomes in patients with high-risk PE undergoing …

Infection with SARS-CoV-2 variant Omicron is considered to be less severe than infection
with variant Delta, with rarer occurrence of severe disease requiring intensive care. Little …

Objective Catecholamines have been the mainstay of pharmacological treatment of
cardiogenic shock (CS). Recently, use of epinephrine has been associated with detrimental …